logo
ScreenersREIT EarningsREIT SectorsMarketplaceLearn
Logo

ProShares Ultra Nasdaq Biotechnology

BIB

The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.‏‏‎ ‎

ProShares

ETF

Equity

- years

225 holdings

Price

per share adjusted in USD

$58.73

Price

+2.78%

$1.59

$57.14

Previous Close

$58.99

Open

Premium

52w Discount
Market Cap

$52.456m

Small

$13.606k

Avg Volume
Assets Under Management

$82.688m

$62.18

NAV

0.95%

Expense Ratio

Dividends

Ex-Dividend: June 25, 25

0.29%

Yield

$0.17

Dividend

ANNUALLY

Dividends

Dividend history
No items found.
Yield
Benchmark
Sectors

1

Sectors
Top 100 Holdings

225

Holdings

2025-08-25

Updated on
↑ TopSummaryPriceDividendsHoldings
logo
About usFAQ
All the information presented is collected from official and public documents such as: Quarterly and Annual Reports, 10-K (US), Information Form (Canada), Presentations and the Investor Relations (IR) section of the company's website.
The data displayed by alreits.com is solely for informational purposes, we do not recommend the buying, holding or selling of any of the stocks on the website. If you have no experience in the stock market, please talk to your personal licensed investment advisor before making any decisions.